Interest in the ear, nose, and throat (ENT) market has increased recently, and the arena now boasts several large device manufacturers that see possibilities in this space for innovative new minimally invasive products. Such competition is the ideal landscape for innovation, as the large companies battle for market share while start-up firms and venture capitalists see opportunities to take the market in new directions. Of course, a variety of conditions make up the ENT market, but therapies for sinus conditions, particularly chronic sinusitis, are developing into an early area of intense competition. The potential growth in this market is due not only to increased competition, but also to the sizeable patient base as well as reimbursement rates that are favorable for physicians right now.
The surgical ENT market, including the sinus surgery segment, has long been dominated by Medtronic PLC, which still holds the largest market share, and other major players in the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?